DK169545B1 - alfa-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneddikesyre-aminsalte, farmaceutiske præparater af disse samt deres anvendelse til fremstilling af farmaceutiske produkter med lipoxygenaseaktivitet og leukotrien-antagonistaktivitet og cellebeskyttende aktivitet - Google Patents

alfa-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneddikesyre-aminsalte, farmaceutiske præparater af disse samt deres anvendelse til fremstilling af farmaceutiske produkter med lipoxygenaseaktivitet og leukotrien-antagonistaktivitet og cellebeskyttende aktivitet Download PDF

Info

Publication number
DK169545B1
DK169545B1 DK117590A DK117590A DK169545B1 DK 169545 B1 DK169545 B1 DK 169545B1 DK 117590 A DK117590 A DK 117590A DK 117590 A DK117590 A DK 117590A DK 169545 B1 DK169545 B1 DK 169545B1
Authority
DK
Denmark
Prior art keywords
activity
methyl
quinolinylmethoxy
naphthalene acetic
acetic acid
Prior art date
Application number
DK117590A
Other languages
Danish (da)
English (en)
Other versions
DK117590D0 (da
DK117590A (da
Inventor
Iii Anthony Frank Kreft
John Henry Musser
James Jacob Bicksler
John William Giberson
Dennis Martin Kubrak
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of DK117590D0 publication Critical patent/DK117590D0/da
Publication of DK117590A publication Critical patent/DK117590A/da
Application granted granted Critical
Publication of DK169545B1 publication Critical patent/DK169545B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DK117590A 1989-05-12 1990-05-10 alfa-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneddikesyre-aminsalte, farmaceutiske præparater af disse samt deres anvendelse til fremstilling af farmaceutiske produkter med lipoxygenaseaktivitet og leukotrien-antagonistaktivitet og cellebeskyttende aktivitet DK169545B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/351,119 US4960892A (en) 1988-06-10 1989-05-12 Naphthalenepropionic acid derivatives as anti-inflammatory/anti-allergic agents
US35111989 1989-05-12

Publications (3)

Publication Number Publication Date
DK117590D0 DK117590D0 (da) 1990-05-10
DK117590A DK117590A (da) 1990-11-13
DK169545B1 true DK169545B1 (da) 1994-11-28

Family

ID=23379653

Family Applications (1)

Application Number Title Priority Date Filing Date
DK117590A DK169545B1 (da) 1989-05-12 1990-05-10 alfa-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneddikesyre-aminsalte, farmaceutiske præparater af disse samt deres anvendelse til fremstilling af farmaceutiske produkter med lipoxygenaseaktivitet og leukotrien-antagonistaktivitet og cellebeskyttende aktivitet

Country Status (15)

Country Link
US (1) US4960892A (de)
EP (1) EP0396839B1 (de)
JP (1) JPH02311463A (de)
KR (1) KR900018033A (de)
AT (1) ATE104281T1 (de)
AU (1) AU629868B2 (de)
CA (1) CA1331001C (de)
DE (1) DE68914646T2 (de)
DK (1) DK169545B1 (de)
ES (1) ES2063143T3 (de)
GB (1) GB2231570B (de)
IE (1) IE61967B1 (de)
IL (1) IL92083A0 (de)
NZ (1) NZ231255A (de)
ZA (1) ZA898291B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
US5208344A (en) * 1987-07-31 1993-05-04 American Home Products Corporation Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
EP0540165A1 (de) * 1991-10-03 1993-05-05 Zeneca Limited Alkonsäurederivate
ES2058024B1 (es) * 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
ES2124196B1 (es) * 1997-06-04 1999-12-01 Menarini Lab Procedimiento para la fabricacion de una forma farmaceutica semisolida conteniendo dexketoprofeno trometamol y su utilizacion en el tratamiento topico de la inflamacion.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
DE2134672A1 (de) * 1971-07-08 1973-01-25 Josef Dipl Chem Dr Rer N Klosa Wasserloesliches acetylsalicylsaeuresalz, dessen herstellung, zubereitung und anwendung
US4097674A (en) * 1975-03-17 1978-06-27 Syntex Corporation 2-Naphthylacetic acid derivatives
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4754043A (en) * 1985-10-03 1988-06-28 American Home Products Corporation Oxazole and thiazole naphthalenes as antiallergic agents
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
AU611699B2 (en) * 1987-07-31 1991-06-20 American Home Products Corporation Naphthalene propionic acid derivatives
WO1998056574A1 (en) * 1997-06-12 1998-12-17 Northrop Grumman Corporation Heat resistant composite structure

Also Published As

Publication number Publication date
ATE104281T1 (de) 1994-04-15
JPH02311463A (ja) 1990-12-27
NZ231255A (en) 1991-02-26
IL92083A0 (en) 1990-07-12
EP0396839B1 (de) 1994-04-13
GB8924501D0 (en) 1989-12-20
EP0396839A2 (de) 1990-11-14
EP0396839A3 (de) 1991-06-05
DK117590D0 (da) 1990-05-10
DE68914646T2 (de) 1994-07-21
DK117590A (da) 1990-11-13
DE68914646D1 (de) 1994-05-19
KR900018033A (ko) 1990-12-20
AU629868B2 (en) 1992-10-15
GB2231570A (en) 1990-11-21
IE61967B1 (en) 1994-11-30
GB2231570B (en) 1992-05-20
CA1331001C (en) 1994-07-26
AU4436189A (en) 1990-11-15
ZA898291B (en) 1991-06-26
IE893519L (en) 1990-11-12
US4960892A (en) 1990-10-02
ES2063143T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
CA1267146A (en) 2-naphthalens substituted quinoline compounds
US5541205A (en) Aryl-n-hydroxyureas as inhbitors of 5-lipoxygenase and anti-arteriosclerotic agents
CA1283419C (en) Substituted di-t-butylphenols
DK169545B1 (da) alfa-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneddikesyre-aminsalte, farmaceutiske præparater af disse samt deres anvendelse til fremstilling af farmaceutiske produkter med lipoxygenaseaktivitet og leukotrien-antagonistaktivitet og cellebeskyttende aktivitet
US4594425A (en) Heterocyclic compounds as antiallergic agents
US4642347A (en) 3(2-quinolinylalkoxy)phenols
AU618764B2 (en) Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
US4058559A (en) 4-Aroyl-substituted phenoxy acetic acids
US5504097A (en) N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US4968710A (en) Substituted di-t-butylphenols and anti-allergic use thereof
US4166819A (en) 4-Aroyl substituted phenoxy methylene-5-tetrazoles
NO169648B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
AU613614B2 (en) Di-t-butylphenyl alkyl and benzyl ethers
US4528392A (en) Aromatic compounds as antiallergic agents
HU192056B (en) Process for production og new tetrasolile derivatives
US5066822A (en) Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
US4554355A (en) Heterocyclic compounds as antiallergic agents
US5731310A (en) Benzene derivatives and pharmaceutical composition
JPH0717588B2 (ja) 置換ジ−t−ブチルフエノ−ル類
US4189607A (en) Anilionotropone derivatives
US4454155A (en) Pharmaceutical compositions containing a mono-substituted derivative of 4-phenyl-4-oxobuten-2-oic acid, and methods of using them in treating gastric and gastroduodenal ailments
JPH02111759A (ja) ヘテラゾールジアルカン酸類
Franchetti et al. Structure-activity relations in reactivators of organophosphorus-inhibited acetylcholinesterase. 7. 1-Aryl-2-hydroxyiminomethyl-3-methylimidazolium iodides
CA2081462A1 (en) Five-membered ring alkanoic acid leukotriene antagonists
US4061772A (en) Derivatives of the 1,2-diarylethylene and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed